Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection

International Journal of Infectious Diseases

Volumn 33, Issue , 2015, Pages 149-155

  Zheng, Su Jun ^a   Qu, Feng ^b   Li, Jun Feng ^a,c   Zhao, Jing ^a   Zhang, Jing Yun ^a   Liu, Mei ^a   Ren, Feng ^a   Chen, Yu ^a   Zhang, Jin Lan ^b   Duan, Zhong Ping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c LANZHOU UNIVERSITY   (China)

Author keywords

Cirrhosis; Hepatic injury; Hepatitis B virus; Liver biopsy; MELD score; Sphingolipids

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; CERAMIDE; CERAMIDE 1 PHOSPHATE; DIHYDROCERAMIDE; HEXOSYLCERAMIDE; SPHINGOLIPID; SPHINGOMYELIN; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHRONIC HEPATITIS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEPATITIS B VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MODEL FOR END STAGE LIVER DISEASE SCORE; NONHUMAN; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEROLOGY; TANDEM MASS SPECTROMETRY; VIRUS LOAD; BLOOD; HEPATITIS B; MIDDLE AGED; VIROLOGY;

ADULT; BIOMARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SPHINGOMYELINS; TANDEM MASS SPECTROMETRY;

EID: 84923021864     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.01.020     Document Type: Article

References (23)

1. Tsochatzis E.A., Bosch J., Burroughs A.K. Liver cirrhosis. Lancet 2014, 383:1749-1761.
2. Perz J.F., Armstrong G.L., Farrington L.A., Hutin Y.J., Bell B.P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006, 45:529-538.
3. Guidotti L.G., Chisari F.V. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 2006, 1:23-61.
4. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
5. Trepo C., Chan H.L., Lok A. Hepatitis B virus infection. Lancet 2014.
6. Bartke N., Hannun Y.A. Bioactive sphingolipids: metabolism and function. J Lipid Res 2009, 50 Suppl:S91-S96.
7. Lingwood D., Simons K. Lipid rafts as a membrane-organizing principle. Science 2010, 327:46-50.
8. Wymann M.P., Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008, 9:162-176.
9. Hannun Y.A., Obeid L.M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008, 9:139-150.
10. Hawkes D.J., Mak J. Lipid membrane; a novel target for viral and bacterial pathogens. Curr Drug Targets 2006, 7:1615-1621.
11. Tatematsu K., Tanaka Y., Sugiyama M., Sudoh M., Mizokami M. Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication. J Med Virol 2011, 83:587-593.
12. Woltman A.M., Ter Borg M.J., Binda R.S., Sprengers D., von Blomberg B.M., Scheper R.J., et al. Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial. Antivir Ther 2009, 14:809-818.
13. Li J.F., Qu F., Zheng S.J., Ren J.Y., Wu H.L., Liu M., et al. Plasma sphingolipids as potential indicators of hepatic necroinflammation in patients with chronic hepatitis C and normal alanine aminotransferase level. PLoS One 2014, 9:e95095.
14. Li J.F., Qu F., Zheng S.J., Wu H.L., Liu M., Liu S., et al. Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis C virus infection. Eur J Clin Microbiol Infect Dis 2014, 33:1725-1732.
15. Qu F., Zheng S.J., Liu S., Wu C.S., Duan Z.P., Zhang J.L. Serum Sphingolipids Reflect the Severity of Chronic HBV Infection and Predict the Mortality of HBV-Acute-on-Chronic Liver Failure. PLoS One 2014, 9:e104988.
16. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009. Hepatology 2009, 50:661-662.
17. Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991, 13:372-374.
18. Nishimura-Sakurai Y., Sakamoto N., Mogushi K., Nagaie S., Nakagawa M., Itsui Y., et al. Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells. J Gastroenterol 2010, 45:523-536.
19. Jalan R., Gines P., Olson J.C., Mookerjee R.P., Moreau R., Garcia-Tsao G., et al. Acute-on chronic liver failure. J Hepatol 2012, 57:1336-1348.
20. Londono M.C., Cardenas A., Guevara M., Quinto L., de Las Heras D., Navasa M., et al. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 2007, 56:1283-1290.
21. Hudacko R., Theise N. Liver biopsies in chronic viral hepatitis: beyond grading and staging. Arch Pathol Lab Med 2011, 135:1320-1328.
22. Fernandez A., Matias N., Fucho R., Ribas V., Von Montfort C., Nuno N., et al. ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading. J Hepatol 2013, 59:805-813.
23. Llacuna L., Mari M., Garcia-Ruiz C., Fernandez-Checa J.C., Morales A. Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology 2006, 44:561-572.